Get the Stockscreener App
22.28
5.21%
1.16
Tyra Biosciences Inc stock is traded at $22.28, with a volume of 202.93K.
It is up +5.21% in the last 24 hours and up +56.15% over the past month.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
See More
Previous Close:
$21.12
Open:
$21.11
24h Volume:
202.93K
Relative Volume:
0.72
Market Cap:
$1.18B
Revenue:
-
Net Income/Loss:
$-83.74M
P/E Ratio:
-13.84
EPS:
-1.61
Net Cash Flow:
$-64.98M
1W Performance:
+39.75%
1M Performance:
+56.15%
6M Performance:
+139.18%
1Y Performance:
+40.37%
1-Day Range:
$20.43
$22.54
1-Week Range:
$14.84
$22.54
52-Week Range:
$6.42
$22.54
Tyra Biosciences Inc Stock (TYRA) Company Profile
Name
Tyra Biosciences Inc
Sector
Industry
Phone
(619) 728-4760
Address
2656 STATE STREET, CARLSBAD
Compare TYRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
22.13 | 1.13B | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.19 | 108.28B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
759.12 | 79.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.34 | 57.65B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
897.50 | 56.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
203.16 | 42.39B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Initiated | Raymond James | Strong Buy |
| May-21-25 | Resumed | Piper Sandler | Overweight |
| Jan-07-25 | Initiated | UBS | Buy |
| Oct-18-24 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-15-24 | Initiated | Piper Sandler | Overweight |
| Dec-15-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-30-23 | Initiated | Wedbush | Outperform |
| Feb-03-23 | Initiated | Oppenheimer | Outperform |
| Jun-23-22 | Initiated | H.C. Wainwright | Buy |
| Mar-08-22 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-21 | Downgrade | Jefferies | Buy → Hold |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Jefferies | Buy |
View All
Tyra Biosciences Inc Stock (TYRA) Latest News
Insiders Who Sold US$628k Of Tyra Biosciences Made The Right Call - simplywall.st
Tyra Biosciences stock hits 52-week high at 21.19 USD By Investing.com - Investing.com Nigeria
Is Tyra Biosciences Inc a good long term investmentShort Selling Opportunities & Accelerate Capital Gains - earlytimes.in
Tyra Biosciences stock hits 52-week high at 21.19 USD - Investing.com
Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year HighHere's What Happened - MarketBeat
There is no doubt that Tyra Biosciences Inc (TYRA) ticks all the boxes. - Setenews
Tyra Biosciences Insider Sold Shares Worth $2,030,923, According to a Recent SEC Filing - MarketScreener
Is Tyra Biosciences Inc. stock supported by strong fundamentalsJuly 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
Tyra Biosciences COO Bensen sells $2m in stock By Investing.com - Investing.com Canada
Insider Sell: Daniel Bensen Sells 125,589 Shares of Tyra Bioscie - GuruFocus
Risk vs reward if holding onto Tyra Biosciences Inc.Weekly Investment Recap & Fast Entry Momentum Trade Alerts - newser.com
Can technical indicators confirm Tyra Biosciences Inc.’s reversalQuarterly Earnings Report & Expert Curated Trade Ideas - newser.com
Will Tyra Biosciences Inc. continue its uptrendEarnings Risk Report & Fast Gain Stock Tips - newser.com
Should I hold or sell Tyra Biosciences Inc. stock in 2025Trade Volume Summary & Daily Stock Trend Watchlist - newser.com
Is Tyra Biosciences Inc. forming a reversal patternMarket Sentiment Report & Low Risk Profit Maximizing Plans - newser.com
Has Tyra Biosciences Inc. found a price floorJobs Report & Momentum Based Trading Signals - newser.com
How to track smart money flows in Tyra Biosciences Inc.2025 Technical Patterns & Fast Entry Momentum Alerts - newser.com
Tyra Biosciences (NASDAQ:TYRA) Trading Up 8.4%Should You Buy? - MarketBeat
BofA Securities Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $28 - 富途牛牛
Tyra Biosciences Insider Sold Shares Worth $2,108,067, According to a Recent SEC Filing - MarketScreener
Tyra Biosciences COO Bensen sells $2.1M in stock By Investing.com - Investing.com Canada
Is Tyra Biosciences Inc. stock attractive for long term wealth building2025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com
Signal strength of Tyra Biosciences Inc. stock in tech scannersMarket Movement Recap & Free Weekly Watchlist of Top Performers - newser.com
Heatmap analysis for Tyra Biosciences Inc. and competitorsEarnings Overview Summary & Capital Protection Trade Alerts - newser.com
Will Tyra Biosciences Inc. stock rally after Fed decisions2025 Risk Factors & Free Low Drawdown Momentum Trade Ideas - newser.com
How Tyra Biosciences Inc. stock performs during Fed tightening cycles2025 Technical Overview & Safe Capital Growth Tips - newser.com
Is Tyra Biosciences Inc. stock trading near support levelsJuly 2025 Update & Short-Term Trading Opportunity Alerts - newser.com
FY2025 EPS Forecast for Tyra Biosciences Boosted by Analyst - Defense World
Tyra Biosciences Inc Stock (TYRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tyra Biosciences Inc Stock (TYRA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bensen Daniel | Chief Operating Officer |
Nov 18 '25 |
Sale |
16.07 |
75,633 |
1,215,627 |
220,937 |
| Bensen Daniel | Chief Operating Officer |
Nov 19 '25 |
Sale |
16.32 |
49,956 |
815,297 |
170,981 |
0.58%
5.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):